Dr. Kwong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
260 International Cir
San Jose, CA 95119Phone+1 408-972-7000
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1998 - 2001
- New York Medical CollegeClass of 1998
Certifications & Licensure
- CA State Medical License 2004 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 39 citationsPostchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer.Myron S. Kwong, Gina G. Chung, Laura J. Horvath, Barbara A. Ward, Arlene D. Hsu
Cancer Journal. 2006-05-01 - 7 citationsPaired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0...Howard West, James C. Moon, Antoinette J. Wozniak, Philip C. Mack, Fred R. Hirsch
Clinical Lung Cancer. 2018-01-01 - 65 citationsCisplatin, Fluorouracil, and Leucovorin Induction Chemotherapy Followed by Concurrent Cisplatin Chemoradiotherapy for Organ Preservation and Cure in Patients With Adva...Amanda Psyrri, Myron S. Kwong, Susan A. DiStasio, L. Lekakis, Mohamad Kassar
Journal of Clinical Oncology. 2004-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: